Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

TGM3 is important for skin and hair structure and may help diagnose cancer.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Mice with human skin protein K8 had more skin problems and cancer.

Lower SMAD2/3 activation predicts more severe skin cancer.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Finasteride does not prevent bladder cancer.

Semecarpus anacardium leaf extract fights breast cancer and extends survival in mice.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.